Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
基本信息
- 批准号:10665769
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2023-10-16
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAdoptive Cell TransfersAntigensAreaAutoantigensBiological AssayCD28 geneCD80 geneCell Adhesion MoleculesCell SizeCell Surface ReceptorsCell SurvivalCell membraneCell physiologyCell surfaceCellsChemicalsCommunicationComplexCytotoxic T-LymphocytesDNADiscriminationDoctor of PhilosophyDoseDrug Delivery SystemsDrug ModulationEngineeringEnvironmentEventFlow CytometryFluorescenceGoalsGranzymeImmuneImmune responseImmunologyInduction of ApoptosisInfusion proceduresIntegrinsIntercellular JunctionsIntercellular adhesion molecule 1InvestigationLigandsLinkLymphocyte FunctionMalignant NeoplasmsMeasurementMeasuresMechanicsMediatingMethodsMinorMolecularNaturePLAUR geneParticle SizePatientsPatternPeptide FragmentsPeptide HydrolasesPeptidesPharmaceutical PreparationsPhasePlasma CellsPostdoctoral FellowProliferatingProteinsResearchResearch Project GrantsRoleScanningScienceSeaSeminalSignal TransductionSpecificitySpectrum AnalysisSpeedSurfaceSynapsesT cell regulationT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTestingTherapeuticTimeTissuesTouch sensationTractionTransfusionTumor AntigensWorkadaptive immune responseantigen bindingantigen detectioncancer cellcancer immunotherapycancer therapychemical propertycytokinecytotoxiccytotoxicitydesigneffective therapyexhaustionfightingimmune modulating agentsimmune reconstitutionimmunoengineeringimmunological synapseimmunological synapse formationimprovedlaser tweezermechanical forcemechanical signalmechanotransductionmigrationmolecular mechanicsmutantnanodeviceoptic tweezerparticleperforinpermissivenessphysical propertypost-doctoral trainingreceptorreceptor bindingresponsesensorside effectsingle moleculeskillsspatiotemporaltooltool developmenttransmission processtumortumor eradicationunpublished works
项目摘要
PROJECT SUMMARY
In the adaptive immune response, cytotoxic T lymphocyte (CTL) continuously “crawl” seeking evidence of foreign
peptide fragments on the surface of other cells. Once the T cell encounters a target cell with foreign or mutant
peptides, then it is activated unleashing a potent immune response. Emerging evidence suggests that cell
mechanical forces transmitted to the T cell receptor (TCR) contribute to its high specificity in antigen recognition
and promote T-cell activation. This is not surprising, as the TCR and other T cell co-receptors bind their cognate
ligands only when two dynamic cells physically “touch”. As a first step toward understanding the role of molecular
forces in tuning T cell response, it is important that we measure the magnitude of forces transmitted to ligand-
receptor complexes and then to relate mechanical events to signaling and functional responses.
My PhD research (F99 phase) has focused on developing methods to measure and elucidate the role of
mechanical forces in immune response. I have designed a microparticle tension senor that allows one to quantify
receptor forces in high throughput and also to measure forces at curved cell junctions. Additionally, I used this
assay to screen the dose-response function of drugs that modulate cell mechanics. Because T cell responses
are fine tuned by an array of co-receptors, I tested the role of mechanics in LFA-1 function. In this work, I
demonstrated that the magnitude of LFA-1 integrin forces fine tunes TCR triggered activation and antigen
discrimination. In addition, I revealed mechanically active LFA-1 defines the permissive zones for cytotoxic
secretion, and suppression of LFA-1 forces significantly abrogates cytotoxicity.
My work suggests that receptors cooperate to tune T-cell responses. For the remainder of my F99 phase,
I will investigate the mechano-communication between receptor forces. Specifically, I will develop a DNA origami
nano device to pattern ligands and measure spatiotemporal colocalization of mechanical events. Afterwards, I
will proceed to test this hypothesis on cell plasma membrane by engineering tension probes on the surface of
living cells. This will enable one to control and measure TCR-forces at authentic cell-cell junctions that mimic the
chemical and physical properties of the immune synapse.
For my postdoctoral work (K00 phase), I aim to improve upon current cancer therapies by leveraging T
cell mechanics in boosting the specificity of immune response. In adoptive cell therapy (ACT), after therapeutic
T-cell reinfusion, adjuvant drugs such as cytokines need to be administered to boost immune reconstitution.
However, nonspecific drug release causes side effects and T-cell exhaustion. To address this challenge, I will
decorate T-cells with DNA cages that mechanically trigger the release of encapsuled drugs at the tumor zone. If
successful, this work will significantly enhance the ACT efficiency and offer the first example that links
mechanobiology to cancer immunotherapy.
项目摘要
在适应性免疫响应中,细胞毒性T淋巴细胞(CTL)继续“爬行”,寻求外国的证据
其他细胞表面上的肽片段。一旦T细胞遇到具有外国或突变体的目标细胞
肽,然后被激活释放潜在的免疫响应。新兴证据表明细胞
传播到T细胞受体(TCR)的机械力在抗原识别中有助于其高特异性
并促进T细胞激活。这并不奇怪,因为TCR和其他T细胞共受体结合其同源
仅当两个动态细胞在物理上“触摸”时,配体。作为理解分子作用的第一步
调整T细胞反应的力,重要的是要测量传递给配体的力的大小
受体复合物,然后将机械事件与信号传导和功能响应相关联。
我的博士研究(F99阶段)致力于开发衡量和阐明的作用的方法
免疫响应中的机械力。我设计了一个微颗粒张力剂,可以量化
高吞吐量的受体力量,并在弯曲的细胞连接处测量力。另外,我用了
测定调节细胞力学的药物的剂量反应功能。因为T细胞反应
通过一系列共受体调节,我测试了力学在LFA-1功能中的作用。在这项工作中,我
证明LFA-1整联蛋白的大小力量微调TCR触发了激活和抗原
歧视。此外,我揭示了机械活性的LFA-1定义了细胞毒性的允许区域
分泌和抑制LFA-1力显着消除了细胞毒性。
我的工作表明接收器协调调整T细胞响应。在我的F99阶段的其余部分中,
我将研究受体力之间的机械通信。具体来说,我将发展一个DNA折纸
纳米装置以模拟配体和测量机械事件的时空共定位。之后,我
将继续通过工程张力问题在细胞质膜上检验这一假设
活细胞。这将使人们能够在真实的细胞 - 细胞连接处控制和测量TCR-Forces,以模仿
免疫非吸管的化学和物理特性。
对于我的博士后工作(K00阶段),我的目标是通过利用T来改善当前的癌症疗法
在增强免疫反应的特异性方面的细胞力学。在治疗后自适应细胞疗法(ACT)
T细胞再灌注,可调节的药物(例如细胞因子)需要施用以增强免疫重建。
但是,非特异性药物释放会导致副作用和T细胞疲劳。为了应对这一挑战,我将
用DNA笼子装饰T细胞,该蛋白笼可以机械地触发肿瘤区域封装药物的释放。如果
成功,这项工作将大大提高行动效率,并提供第一个链接的示例
癌症免疫疗法的机械生物学。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuesong Hu其他文献
Yuesong Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuesong Hu', 18)}}的其他基金
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
相似国自然基金
穿透性靶向胰腺癌内cDC1的纳米佐剂调控溶酶体逃逸促进放疗诱导ICD的机制研究
- 批准号:82303680
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多级改造的工程化外泌体自佐剂疫苗平台实现鼻上皮细胞感染拟态和粘膜递送的研究
- 批准号:32371440
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
展示PD-L1抗体的纳米锰佐剂联合放疗以诱导原位肿瘤疫苗的产生及其机制的探究
- 批准号:32371518
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
应用于冠状病毒广谱疫苗开发的新型全链式免疫增强型佐剂研究
- 批准号:82341036
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
用于载药 CAR T 细胞的新型纳米载体技术的设计
- 批准号:
10734365 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
通过嵌合受体加强疫苗增强 CAR-T 细胞对抗实体瘤的活性
- 批准号:
10540783 - 财政年份:2020
- 资助金额:
$ 4.77万 - 项目类别:
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
通过嵌合受体加强疫苗增强 CAR-T 细胞对抗实体瘤的活性
- 批准号:
10322393 - 财政年份:2020
- 资助金额:
$ 4.77万 - 项目类别:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
德克萨斯大学 MD 安德森癌症中心 SPORE 黑色素瘤
- 批准号:
10415934 - 财政年份:2019
- 资助金额:
$ 4.77万 - 项目类别: